Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(31 sites)
China
The First Affiliated Hospital of Anhui Medical University, Bengbu, Anhui Anhui Provincial Cancer Hospital, Hefei, Anhui The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Peking University First Hospital, Beijing, Beijing Municipality Beijing Shunyi Hospital, Beijing, Beijing Municipality Fujian Cancer Hospital, Fuzhou, Fujian The First Hospital Of Lanzhou University, Lanzhou, Gansu Jiangmen Central Hospital, Jiangmen, Guangdong Affiliated Cancer Hospital Of Guangxi Medical University, Nanning, Guangxi Cancer Hospital Of Guizhou Medical University, Guiyang, Guizhou Hainan General Hospital, Haikou, Hainan The Fourth Hospital Of Hebei Medical University, Shijiazhuang, Hebei Affiliated Cancer Hospital Of Harbin Medical University, Harbin, Heilongjiang Jiamusi Tuberculosis Hospital (Jiamusi Tumor Hospital), Jiamusi, Heilongjiang Anyang Cancer Hospital, Anyang, Henan The First Affiliated Hospital Of Henan University Of Science & Technology, Luoyang, Henan Henan Cancer Hospital, Zhengzhou, Henan Hunan Cancer Hospital, Changsha, Hunan Chifeng Municipal Hospital, Chifeng, Inner Mongolia Jiangxi Cancer Hospital, Nanchang, Jiangxi Jilin Cancer Hospital, Changchun, Jilin The First Hospital of Jilin University, Changchun, Jilin The Second Hospital Of Dalian Medical University, Dalian, Liaoning Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Affiliated Hospital Of Jining Medical University, Jining, Shandong Linyi Cancer Hospital, Linyi, Shandong Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality Dazhopu Central Hospital, Dazhou, Sichuan Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality Hangzhou Cancer Hospital, Hangzhou, Zhejiang